NKNa Yeon Kwon

Na Yeon Kwon

*This is an algorithmically generated author record based on publicly available information.

Na Yeon Kwon has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Asymmetric Synthesis of S -Trifluoromethyl Sulfoxide and Sulfoximine Pharmacophores

    by Na Yeon Kwon, Justin Ye, Jonathan A. Ellman

    Chiral sulfoxides and sulfoximines are present in many approved drugs and clinical candidates, and as predicated by the extensive use of the trifluoromethyl group in medicinal chemistry, S-trifluoromethyl derivatives with potent biological activity have been reported. However, chiral S-trifluoromethyl sulfoxides and sulfoximines are underexplored, perhaps because the only published routes for their preparation proceed by racemic synthesis followed by chiral separation. Here we report the asymmetric syntheses of S-trifluoromethyl sulfoxides and sulfoximines utilizing highly enantioenriched S-trifluoromethyl sulfilimines as common intermediates, obtained by the enantioselective copper-catalyzed S-trifluoromethylation of a wide range of sulfenamides, including complex drug and natural product derivatives. Methods were developed for the efficient conversion of the S-trifluoromethyl sulfilimines to sulfoxides via hydrolysis with inversion and sulfoximines via oxidation with retention. Mechanistic studies of the conversion of S-trifluoromethyl sulfilimines to sulfoxides reveal that the sulfilimine N-acyl group is first cleaved to give the free-NH sulfilimine that then undergoes hydrolysis by backside displacement of the amine to give the sulfoxide with inversion of stereochemistry.


  • Top Cited Papers

    Ruthenium-Catalyzed Enantioselective Alkylation of Sulfenamides: A General Approach for the Synthesis of Drug Relevant S-Methyl and S-Cyclopropyl Sulfoximines

    by Zachary W. Boyer, Na Yeon Kwon, Jonathan A. Ellman

    Sulfoximines are increasingly utilized in pharmaceuticals and agrochemicals with all sulfoximine clinical candidates incorporating either an S-methyl or an S-cyclopropyl substituent. Here, we report on a general and efficient sequence for the asymmetric synthesis of both of these sulfoximine substitution patterns. The asymmetric synthesis of sulfilimine intermediates by the first Ru-catalyzed enantioselective alkylation of sulfenamides enables the first examples of enantioselective S-alkylation with monosubstituted diazo compounds. The reaction proceeds at ≤1 mol % Ru-catalyst loading, and for tert-butyl diazoacetate, high yields and ≥98:2 er are achieved for an exceedingly broad range of sulfenamides, including with S-(hetero)aryl, -alkenyl, -methyl, -benzyl, -branched alkyl, and -tert-butyl substituents and for sterically and electronically diverse N-acyl groups. Sulfenamides derived from densely functionalized advanced drug intermediates also alkylated with 99:1 er. After oxidation of an N-pivaloyl S-tert-butyl acetate substituted sulfilimine to the corresponding sulfoximine, treatment with trifluoracetic acid in an aprotic solvent resulted in decarboxylation to the S-methyl N-pivaloyl sulfoximine, while aqueous HCl resulted in both decarboxylation and cleavage of the N-acyl group to give the S-methyl NH sulfoximine. Alternatively, sulfoximine alkylation with dibromoethane followed by acid-mediated decarboxylation provided the S-cyclopropyl sulfoximine. The efficient asymmetric synthesis of the preclinical candidate LTGO-33 and the formal asymmetric synthesis of the phase II clinical candidate ART0380 demonstrate the utility of the disclosed approach.


  • KOtBu-promoted C3-homocoupling of quinoxalinones through single electron transfer from an sp2 carbanion intermediate

    by Na Yeon Kwon, Neeraj Kumar Mishra, Jung Su Park, Sang Kook Woo, Prithwish Ghosh, In Su Kim

    An efficient protocol for the C3-homocoupling reaction of quinoxalinones with potassium tert-butoxide is described. The detailed mechanistic pathway on the single electron transfer (SET) process has been proposed.